Evidence map›Paper›PMID 31888698›Full record

ArticleGenome biology2019

mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.

Joseph A Waldron, David C Tack, Laura E Ritchey, Sarah L Gillen, Ania Wilczynska, Ernest Turro, Philip C Bevilacqua, Sarah M Assmann, Martin Bushell, John Le Quesne

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Identification of RNA structures and their roles in RNA functions.Nature reviews. Molecular cell biology · 2024
    Review
  9. Article
  10. Article
  11. In vivo structure probing of RNA inRNA (New York, N.Y.) · 2023
    Article
  12. Article
  13. Article
  14. International journal of molecular sciences · 2023
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Joseph A WaldronCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. J.Waldron@beatson.gla.ac.uk.
David C TackDepartment of Biology, Pennsylvania State University, University Park, PA, 16802, USA.
Laura E RitcheyDepartment of Chemistry, Pennsylvania State University, University Park, PA, 16802, USA.
Sarah L GillenCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Ania WilczynskaCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Ernest TurroDepartment of Haematology, University of Cambridge, Cambridge, UK.
Philip C BevilacquaDepartment of Chemistry, Pennsylvania State University, University Park, PA, 16802, USA.
Sarah M AssmannDepartment of Biology, Pennsylvania State University, University Park, PA, 16802, USA.
Martin BushellCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. m.bushell@beatson.gla.ac.uk.
John Le QuesneMedical Research Council Toxicology Unit, University of Cambridge, Hodgkin Building, Lancaster Road, Leicester, LE1 7HB, UK. jlq2@leicester.ac.uk.
Pennsylvania State University · USCancer Research UK Scotland Institute · GBCancer Research UK · GBMRC Biostatistics Unit · GBUniversity of Cambridge · GB

Funding

Cancer Research UK 24388Cancer Research UK 29252Cancer Research UK C20673/A24388Medical Research Council MC_UP_1203/1Medical Research Council MC_UP_A600_1024Medical Research Council MC_UU_00025/6
6 · The paper itself

Abstract

backgroundThe RNA helicase eIF4A1 is a key component of the translation initiation machinery and is required for the translation of many pro-oncogenic mRNAs. There is increasing interest in targeting eIF4A1 therapeutically in cancer, thus understanding how this protein leads to the selective re-programming of the translational landscape is critical. While it is known that eIF4A1-dependent mRNAs frequently have long GC-rich 5'UTRs, the details of how 5'UTR structure is resculptured by eIF4A1 to enhance the translation of specific mRNAs are unknown.

resultsUsing Structure-seq2 and polysome profiling, we assess global mRNA structure and translational efficiency in MCF7 cells, with and without eIF4A inhibition with hippuristanol. We find that eIF4A inhibition does not lead to global increases in 5'UTR structure, but rather it leads to 5'UTR remodeling, with localized gains and losses of structure. The degree of these localized structural changes is associated with 5'UTR length, meaning that eIF4A-dependent mRNAs have greater localized gains of structure due to their increased 5'UTR length. However, it is not solely increased localized structure that causes eIF4A-dependency but the position of the structured regions, as these structured elements are located predominantly at the 3' end of the 5'UTR.

conclusionsBy measuring changes in RNA structure following eIF4A inhibition, we show that eIF4A remodels local 5'UTR structures. The location of these structural elements ultimately determines the dependency on eIF4A, with increased structure just upstream of the CDS being the major limiting factor in translation, which is overcome by eIF4A activity.

Indexed as

5' Untranslated RegionsCodon, InitiatorEukaryotic Initiation Factor-4AHumansMCF-7 CellsRNA, MessengerSterols5' Untranslated RegionsCodon, InitiatorEukaryotic Initiation Factor-4AhippuristanolRNA, MessengerSterolsCancerDMSeIF4AG-quadruplexesHippuristanolPolysome profilingRNA structureStructure-seqTranslationTranslation initiation

Identifiers

PMID31888698
PMCPMC6936103
OpenAlexW2998576147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.